Berkshire Hathaway's Q2 2025 Portfolio Review: A Look at Warren Buffett's Investments
Berkshire Hathaway Shifts Portfolio in Q2 2025
Berkshire Hathaway, the conglomerate led by legendary investor Warren Buffett, made several notable changes to its stock portfolio in Q2 2025. The changes, revealed in the company's latest 13F filing, include new investments, disposals, and adjustments to existing positions.
The most significant new addition is UnitedHealth Group (UNH), a leading healthcare company. Berkshire purchased more than 5 million shares of UNH, valued at approximately $1.6 billion, marking a significant step into healthcare for the conglomerate.
One of the largest tech companies, Apple Inc. (AAPL), saw a trimming of about 7% in Q2 2025. Berkshire also reduced its Apple holding by 20 million shares, lowering its exposure by approximately $9.2 billion. Despite the reduction, Apple remains Berkshire's largest equity stake by market value.
Berkshire also sold 26 million shares of Bank of America, lowering its stake to roughly 8%, indicating a more cautious stance on banking.
In addition to these changes, Berkshire increased its holdings in several existing stocks, although the specific names and amounts were not exhaustively detailed. The company's top five positions account for about 75% of the portfolio.
Notable positions that experienced increases include Chevron Corp (CVX), which saw a 14% stake increase during Q2 2025, and VeriSign Inc. (VRSN), whose position more than doubled in Q1 2013.
Other companies, such as Amazon.com (AMZN), D. R. Horton (DHI), Lennar Corp (LEN.B), and Nucor Corp (NUE), had their positions increased this quarter.
The portfolio turnover rose to about 5.26% in Q2, signaling increased activity compared to previous quarters. Berkshire Hathaway also maintained large cash reserves, reflecting a disciplined approach awaiting better market opportunities.
The changes suggest a strategic shift toward value investing and diversification, with a notable step into healthcare via UnitedHealth. Berkshire Hathaway's Q2 2025 13F filing reveals a dynamic and evolving portfolio.
Berkshire Hathaway, in its Q2 2025 portfolio, made a foray into the healthcare sector by investing in UnitedHealth Group, valued at approximately $1.6 billion. The conglomerate also showed a careful approach in the finance industry by selling 26 million shares of Bank of America, lowering its stake significantly.
